Patents by Inventor Anne Endmann

Anne Endmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Bacterial vector
    Patent number: 8093025
    Abstract: The present invention relates to a combination of compounds for introducing nucleic acids and/or protein into animal cells, tissue, organs or organisms in vitro, extracorporal, or in vivo. This combination comprises preparations suitable for administration to an animal or human for medical purposes, comprising as one component a bacterial vector genetically manipulated to contain nucleic acid sequences comprising a transgene, and a second component for the subsequent transcription, possibly translation of the transgene by controlled induction of bacterial vector as it is present within the animal or human.
    Type: Grant
    Filed: September 2, 2005
    Date of Patent: January 10, 2012
    Assignee: Helmholtz-Zentrum fuer Infektionsforschung GmbH
    Inventors: Holger Loessner, Anne Endmann, Sara Leschner, Siegfried Weiss
  • Bacterial Vector
    Publication number: 20080112928
    Abstract: The present invention relates to a combination of compounds for introducing nucleic acids and/or protein into animal cells, tissue, organs or organisms in vitro, extracorporal, or in vivo. This combination comprises preparations suitable for administration to an animal or human for medical purposes, comprising as one component a bacterial vector genetically manipulated to contain nucleic acid sequences comprising a transgene, and a second component for the subsequent transcription, possibly translation of the transgene by controlled induction of bacterial vector as it is present within the animal or human.
    Type: Application
    Filed: September 2, 2005
    Publication date: May 15, 2008
    Inventors: Holger Loessner, Anne Endmann, Sara Leschner, Siegfried Weiss